Phase 4 Crohn's Disease and Colitis Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged between 12 and 25 years old.
- People who have been diagnosed with Crohn's disease (the type affecting the digestive tract) or ulcerative colitis.
- People who are currently receiving infliximab infusions every 8 weeks, or adalimumab injections every 2 weeks.
- People for whom this is their first anti-TNF medication, or who previously used a different anti-TNF medication that was stopped for a reason other than it not working or stopping to work over time.
- People who have never had their dosing schedule spaced out or extended before.
- People who have had three stool (poo) sample tests in a row, taken within the past 6 months, showing inflammation levels within an acceptable range (below 250 μg/g for Crohn's disease, or below 150 μg/g for ulcerative colitis), or who have had a camera examination of the bowel within the past 2 months confirming their condition is in remission (confirm with trial site for exact scoring details).
- People who are currently not experiencing symptoms of active inflammatory bowel disease, as assessed by their local IBD medical team.
- People who have provided written consent to participate (for those under 18, the relevant consent requirements should be confirmed with the trial site).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a perianal fistula (an abnormal tunnel near the back passage).
- People who have had a stoma bag (ileostomy) or an internal pouch surgically created from the bowel (ileoanal pouch).
- People who have another inflammatory condition, such as rheumatoid arthritis.
- People who are currently taking steroid medications such as prednisone or budesonide.
- People who are currently pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
cumulative incidence of out-of-range fecal calprotectin results at 48 weeks follow-up
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.